These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 116431)

  • 21. Hemolytic disease of the newborn from anti-E. A case report.
    Strohm PL; Iams JD; Kennedy MS
    J Reprod Med; 1988 Apr; 33(4):404-6. PubMed ID: 3130484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Fy3 in sickle cell disease: a difficult transfusion problem.
    Went R; Wright J; Webster R; Stamps R
    Br J Haematol; 2009 Feb; 144(4):621-2. PubMed ID: 19055658
    [No Abstract]   [Full Text] [Related]  

  • 23. Two examples of an inseparable antibody that reacts equally well with DW+ and Rh32+ red blood cells.
    Reid ME; Sausais L; Zaroulis CG; Mohandas K; Coghlan G; Lomas-Francis C
    Vox Sang; 1998; 75(3):230-3. PubMed ID: 9852412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rare case of sensitization to factors of Rh-Hr systems and hemotransfusion complications].
    Revinskaia RI
    Probl Gematol Pereliv Krovi; 1974 Apr; 19(4):50-1. PubMed ID: 4209011
    [No Abstract]   [Full Text] [Related]  

  • 25. [Transfusion of blood incompatible with Rh factor: evolution and use of immunoglobulin anti-D].
    Almuna R; Testa E; Zeldis S; Monterríos E
    Rev Chil Obstet Ginecol; 1976; 41(5):267-73. PubMed ID: 829550
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-transfusion crises in sickle cell anemia.
    Milner PF; Squires JE
    Prog Clin Biol Res; 1987; 240():351-9. PubMed ID: 3615499
    [No Abstract]   [Full Text] [Related]  

  • 27. [Handling blood products requires knowledge].
    Bach AB
    Sygeplejersken; 1987 Jul; 87(28):4-6. PubMed ID: 3116697
    [No Abstract]   [Full Text] [Related]  

  • 28. The performance of an anti D immunoprophylaxis scheme.
    Kinnock S; Liley AW
    N Z Med J; 1974 Oct; 80(526):337-43. PubMed ID: 4216865
    [No Abstract]   [Full Text] [Related]  

  • 29. [Accidental case delayed by anti-D allo-immunization in a patient suffering from multiple traumatic injuries. One case (author's transl)].
    Haberer JP; Bidet JM; Abouzit JL; Duband P; Schoeffler P
    Anesth Analg (Paris); 1981; 38(5-6):271-4. PubMed ID: 6791524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of antibody detection and identification in the chronically transfused patient.
    Sandler SG
    Clin Adv Hematol Oncol; 2010 Sep; 8(9):611, 616-7. PubMed ID: 21157410
    [No Abstract]   [Full Text] [Related]  

  • 31. Doctor and hospital sued successfully by child born eight years after injury to mother.
    Wachsman HF
    Leg Aspects Med Pract; 1978 Jul; 6(7):41-3. PubMed ID: 98680
    [No Abstract]   [Full Text] [Related]  

  • 32. Children's National Medical Center's transfusion protocol for sickle hemoglobinopathies.
    Minniti CP; Kratovil T; Luban NL
    Immunohematology; 2006; 22(3):117-20. PubMed ID: 17105359
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of Hodgkin's disease in a patient with sickle cell anemia.
    Salmassi S; Currie ET; Bolf EC; Hernandez M; Kasprisin DO
    Cancer; 1981 Jul; 48(2):252-4. PubMed ID: 6786729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Another example of anti-D in a D-positive patient.
    Early ME
    Am J Clin Pathol; 1974 Feb; 61(2):188-91. PubMed ID: 4204531
    [No Abstract]   [Full Text] [Related]  

  • 35. A second example of anti-Fy51.
    DiNapoli J; Garcia A; Marsh WL; Dreizin D
    Vox Sang; 1976; 30(4):308-11. PubMed ID: 814720
    [No Abstract]   [Full Text] [Related]  

  • 36. Is allosensitization a strong enough reason to avoid transfusions?
    Coyne D
    Nephrol News Issues; 2013 Jun; 27(7):Supp 13-4, Supp 22. PubMed ID: 23855144
    [No Abstract]   [Full Text] [Related]  

  • 37. Allo anti-D production in a D positive patient.
    Roycroft DW; Wientjes M; Lovell D; Young VL
    Va Med; 1979 Nov; 106(11):863. PubMed ID: 116431
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen.
    Larson PJ; Lukas MB; Friedman DF; Manno CS
    Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved response of an Rh-positive patient with aplastic anemia to donor platelet transfusions with intravenous anti-D rhesus antibodies.
    Siemons L; Colpin G; Muylle L; De Bock R; Peetermans ME
    N Engl J Med; 1987 Dec; 317(26):1667-8. PubMed ID: 3120010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.